Merck Tbk. vs Magna Investama Mandiri Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Magna Investama Mandiri Tbk. trades at Rp91 (market cap 310.41B, 614.3K 24h volume). The key difference: Merck Tbk. is far larger — about 5.5× Magna Investama Mandiri Tbk.'s market cap, and Magna Investama Mandiri Tbk. is more actively traded (614.3K versus 37.6K). Which is the better fit depends on your goals.
| MERK | MGNA | |
|---|---|---|
Market Cap | 1.7T | 310.41B |
Volume | 37.6K | 614.3K |
Lot | 376 | 6.14K |
Turnover | 144.47M | 56M |
Average Price | 3,842.23 | 91.16 |
Value | 144.47M | 56M |
Indicative Equilibrium Price | 3,840 | 91 |
Indicative Equilibrium Volume | 7 | 75 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Magna Finance Tbk (the Company) formerly PT Arkasa Utama Leasing was established based on Notarial Deed No. 10 dated March 09, 1984 of James Jacinta Susanti, S.H.
Read more on MGNA →